DEUTSCHE BANK AG\ - NEUROBO PHARMACEUTICALS INC ownership

NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 33 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$104,000
+766.7%
31,090
+1016.3%
0.00%
Q1 2021$12,000
-25.0%
2,785
-9.0%
0.00%
Q4 2020$16,000
+33.3%
3,061
+40.3%
0.00%
Q3 2020$12,000
-25.0%
2,182
+10.8%
0.00%
Q2 2020$16,0001,9700.00%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 182,543$1,026,0000.15%
Hayden Royal, LLC 22,682$127,0000.07%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 6,454$36,0000.00%
UBS Group AG 1,913$11,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,559$14,0000.00%
BANK OF AMERICA CORP /DE/ 2,012$11,0000.00%
Russell Investments Group, Ltd. 28,597$160,0000.00%
WELLS FARGO & COMPANY/MN 1,337$7,0000.00%
NORTHERN TRUST CORP 85,444$479,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders